Identification of novel genes involved in gastric carcinogenesis by suppression subtractive hybridization

Human and Experimental Toxicology

Volumn 34, Issue 1, 2015, Pages 3-11

  Mottaghi Dastjerdi, N ^a,b   Soltany Rezaee Rad, M ^a,b   Sepehrizadeh, Z ^a   Roshandel, G ^c   Ebrahimifard, F ^d   Setayesh, N ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

gastric cancer; Gene expression profiling; oncogene; overexpression; suppression subtractive hybridization

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME C OXIDASE SUBUNIT 2; EUKARYOTIC TRANSLATION INITIATION FACTOR 4A1; L18A PROTEIN; MITOCHONDRIALLY ENCODED ATP SYNTHASE 6; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE SUBUNIT 4; RIBOSOME PROTEIN; RNASE H2 SUBUNIT B PROTEIN; SEC13 PROTEIN; TETRASPANIN 8; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT II; INITIATION FACTOR 4A; MT-ATP6 PROTEIN, HUMAN; NADH DEHYDROGENASE SUBUNIT 4; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBONUCLEASE H; RIBONUCLEASE HII; RIBOSOMAL PROTEIN L18; SEC13 PROTEIN, HUMAN; TETRASPANIN; TSPAN8 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GENETICS; CANCER PROGNOSIS; CANCER RESISTANCE; COMPARATIVE STUDY; DRUG RESPONSE; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; PROTEIN SYNTHESIS; RNA EXTRACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH CANCER; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; ADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETICS; STOMACH TUMOR; SUBTRACTIVE HYBRIDIZATION;

EUKARYOTA;

ADENOCARCINOMA; CARRIER PROTEINS; ELECTRON TRANSPORT COMPLEX IV; EUKARYOTIC INITIATION FACTOR-4A; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; NADH DEHYDROGENASE; RIBONUCLEASE H; RIBOSOMAL PROTEINS; STOMACH NEOPLASMS; SUBTRACTIVE HYBRIDIZATION TECHNIQUES; TETRASPANINS;

EID: 84919667874     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327114532386     Document Type: Article

References (49)

1. Bray F, Ren J, Masuyer E, et al. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Canc. 2013 ; 1: 1133-1145
2. Hussein NR. Helicobacter pylori and gastric cancer in the Middle East: a new enigma?. World J Gastroenterol. 2010 ; 16: 3226-3234
3. Mehrabian A, Esna-Ashari F, Zham H, et al. Gastric cancer prevalence, according to survival data in Iran (National Study-2007). Iran J Public Health. 2010 ; 39: 27-31
4. Roukos DH. Current status and future perspectives in gastric cancer management. Canc Treat Rev. 2000 ; 26: 243-255
5. Boussioutas A, Li H, Liu J, et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Canc Res. 2003 ; 63: 2569-2577
6. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012 ; 4: 156
7. Weiss MM, Kuipers EJ, Postma C, et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene. 2003 ; 22: 1872-1879
8. Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007 ; 446: 153-158
9. Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M, Sepehrizadeh Z, et al. Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance. Daru. 2014 ; 22: 14
10. Moody DE. Genomics techniques: an overview of methods for the study of gene expression. J Anim Sci. 2001 ; 79: E128 - E135
11. Clarke R, Shajahan AN, Wang Y, et al. Endoplasmic reticulum stress, the unfolded protein response, and gene network modeling in antiestrogen resistant breast cancer. Horm Mol Biol Clin Investig. 2011 ; 5: 35-44
12. Kreeger PK, Lauffenburger DA. Cancer systems biology: a network modeling perspective. Carcinogenesis. 2010 ; 31: 2-8
13. Tavassoly I, Shajahan AN, Parmar J, et al. Dynamical modeling of the interaction between autophagy and apoptosis in mammalian cells: a systems pharmacology framework. arXiv preprint arXiv:13127149. 2013 ;:
14. Szala S, Kasai Y, Steplewski Z, et al. Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci USA. 1990 ; 87: 6833-6837
15. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005 ; 6: 801-811
16. Boucheix C, Duc GH, Jasmin C, et al. Tetraspanins and malignancy. Expert Rev Mol Med. 2001 ; 2001: 1-17
17. Wright MD, Moseley GW, van Spriel AB. Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens. 2004 ; 64: 533-542
18. Lazo PA. Functional implications of tetraspanin proteins in cancer biology. Canc Sci. 2007 ; 98: 1666-1677
19. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Canc. 2009 ; 9: 40-55
20. Kanetaka K, Sakamoto M, Yamamoto Y, et al. Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol. 2001 ; 35: 637-642
21. Le Naour F, Andre M, Greco C, et al. Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteomics. 2006 ; 5: 845-857
22. Gesierich S, Paret C, Hildebrand D, et al. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Canc Res. 2005 ; 11: 2840-2852
23. Zhou Z, Ran YL, Hu H, et al. TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12 m expression. Clin Exp Metastasis. 2008 ; 25: 537-548
24. Richardson M, Jennings L, Zhang X. Tetraspanins and tumor progression. Clin Exp Metastasis. 2011 ; 28: 261-270
25. Ruggero D, Pandolfi PP. Does the ribosome translate cancer?. Nat Rev Canc. 2003 ; 3: 179-192
26. Kitahara O, Furukawa Y, Tanaka T, et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Canc Res. 2001 ; 61: 3544-3549
27. Mao-De L, Jing X. Ribosomal proteins and colorectal cancer. Curr Genomics. 2007 ; 8: 43-49
28. Zhao YB, Yang HY, Zhang XW, et al. Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. World J Gastroenterol. 2005 ; 11: 3304-3346
29. Zhou Y, Tozzi F, Chen J, et al. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Canc Res. 2012 ; 72: 304-314
30. Galluzzi L, Morselli E, Kepp O, et al. Mitochondrial gateways to cancer. Mol Aspects Med. 2010 ; 31: 1-20
31. Reichert AS, Neupert W. Mitochondriomics or what makes us breathe. Trends Genet. 2004 ; 20: 555-562
32. Pedersen PL. The cancer cell's "power plants" as promising therapeutic targets: an overview. J Bioenerg Biomembr. 2007 ; 39: 1-12
33. Lemasters JJ, Qian T, He L, et al. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal. 2002 ; 4: 769-781
34. Maximo V, Soares P, Seruca R, et al. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Gene Chromosomes Canc. 2001 ; 32: 136-143
35. Habano W, Sugai T, Nakamura SI, et al. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology. 2000 ; 118: 835-841
36. Cerritelli SM, Crouch RJ. Ribonuclease H: the enzymes in eukaryotes. FEBS J. 2009 ; 276: 1494-1505
37. Hiller B, Achleitner M, Glage S, et al. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med. 2012 ; 209: 1419-1426
38. Bubeck D, Reijns MAM, Graham SC, et al. PCNA directs type 2 RNase H activity on DNA replication and repair substrates. Nucleic Acids Res. 2011 ; 39: 3652-3666
39. Lazzaro F, Novarina D, Amara F, et al Conference Response to DNA damage from molecular mechanism to human disease. 2011:
40. Graff JR, Konicek BW, Carter JH, et al. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Canc Res. 2008 ; 68: 631-634
41. Bauer C, Diesinger I, Brass N, et al. Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer. 2001 ; 92: 822-829
42. Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nat Rev Canc. 2010 ; 10: 254-266
43. Eberle J, Krasagakis K, Orfanos CE. Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Canc. 1998 ; 71: 396-401
44. Shuda M, Kondoh N, Tanaka K, et al. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticanc Res. 2000 ; 20: 2489-2494
45. Sihn CR, Suh EJ, Lee KH, et al. Sec13 induces genomic instability in U2OS cells. Exp Mol Med. 2005 ; 37: 255-260
46. Liang S, Singh M, Gam LH. The differential expression of aqueous soluble proteins in breast normal and cancerous tissues in relation to stage and grade of patients. J Biomed Biotechnol. 2010 ;: 469-516
47. Turner JG, Dawson J, Sullivan DM. Nuclear export of proteins and drug resistance in cancer. Biochem Pharmacol. 2012 ; 83: 1021-1032
48. Lee MC, Miller EA. Molecular mechanisms of COPII vesicle formation. Semin Cell Dev Biol. 2007 ; 18: 424-434
49. Ryan KJ, Wente SR. The nuclear pore complex: a protein machine bridging the nucleus and cytoplasm. Curr Opin Cell Biol. 2000 ; 12: 361-371